uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in very immature newborn infants with nosocomial infections
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences.
In: Eur J Ped, ISSN 0340-6199Article in journal (Refereed) Submitted
URN: urn:nbn:se:uu:diva-92982OAI: oai:DiVA.org:uu-92982DiVA: diva2:166321
Available from: 2005-04-29 Created: 2005-04-29Bibliographically approved
In thesis
1. Serum Amyloid A Protein (SAA) in Healthy and Infected Individuals
Open this publication in new window or tab >>Serum Amyloid A Protein (SAA) in Healthy and Infected Individuals
2005 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Serum amyloid A protein (SAA) is an acute phase protein that has recently gained increasing interest as a potential marker for disease and treatment monitoring. We investigated SAA and CRP levels in (a) patients with various common infectious diseases (n=98), (b) patients with pyelonephritis (n=37) versus patients with cystitis (n=32), (c) healthy individuals of varying ages (n=231), (d) very immature newborn infants with or without nosocomial infections (NIs) (n=72) and (e) patients with bacterial infections treated with cefuroxime (n=81).

SAA significantly correlated with CRP in viral as well as in bacterial infections (for the total group: r2=0.757, p<0.0001) and showed a systemic inflammatory response in 90% of the patients with cystitis as compared with 23% for CRP. Equally high efficiencies (0.96 and 0.94 for SAA and CRP, respectively) were observed in discriminating between pyelonephritis and cystitis. SAA and high sensitive (hs) CRP were lower in umbilical cords (p<0.0001) and higher in elderly adults (p<0.0001-0.03) than in the other age groups; higher in immature newborn infants than in term infants; and higher in the NI group than in the non-NI group. Interindividual variabilities of the time course of the biomarkers SAA and CRP were considerable. Because of the smoothed distribution of SAA and CRP (i.e. elevations were both essentially unchanged during the first 3 days of cefuroxime treatment), these markers were not useful when deciding parenteral-oral switch of therapy, which occurred within this time period in most cases.

SAA is a sensitive systemic marker in cystitis. SAA and hsCRP in umbilical cord blood are close to the detection limit and increase with age. They increase in relation to NI in very immature newborn infants and might therefore be used in diagnosis and monitoring. Finally, SAA and CRP in adults with bacterial infections could not predict an early parenteral-oral switch of antimicrobial therapy.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2005. 50 p.
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 32
Communicable diseases, acute phase proteins, adult, Administration Oral, aminoglycosides, amyloidosis, antibiotics, bacterial infections, body temperature, C-reactive protein, cefuroxime, cystitis, cytokines, elderly, infant, interleukin-6, newborn, pyelonephritis, serum amyloid A protein, virus diseases, Infektionssjukdomar
National Category
Infectious Medicine
urn:nbn:se:uu:diva-5774 (URN)91-554-6233-2 (ISBN)
Public defence
2005-05-24, Rosénsalen, Akademiska sjukhuset, Ing 95/96, Uppsala, 09:15
Available from: 2005-04-29 Created: 2005-04-29Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 76 hits
ReferencesLink to record
Permanent link

Direct link